Moreover, the expression of HMMR is associated with the progression of cancer, such as RHAMM, and has been suggested as a prognostic factor and a potential therapeutic target for pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine (PNET) (61). Here, HMMR is linked to pancreatic ductal adenocarcinoma.